Cholangiocarcinoma is a rare but aggressive malignancy arising from the epithelial cells of the bile ducts, accounting for approximately 10–15% of all primary liver cancers. It is typically classified into intrahepatic and extrahepatic forms, each with distinct biological and clinical features. The incidence of cholangiocarcinoma has been increasing globally, particularly for intrahepatic subtypes, with higher rates observed in regions of Southeast Asia due to risk factors such as liver fluke infections, while in Western countries it is more often associated with chronic liver disease and biliary inflammation. With NextGen.ooo, you can order oncology medications for cholangiocarcinoma treatment and receive them quickly, no matter where you are in the world. Access the therapies you need with confidence and convenience.